Robot | Path | Permission |
GoogleBot | / | ✔ |
BingBot | / | ✔ |
BaiduSpider | / | ✔ |
YandexBot | / | ✔ |
User-Agent: * Disallow: /jsp/utils/ Disallow: /WEB-INF/ Disallow: /epsadmin/ Disallow: /*?source Sitemap: |
Title | Relapsing MS Treatment I KESIMPTA® |
Description | TAKE ON RMS CHALLENGES WITH DRAMATIC For US Residents only Visit US Health Care Professionals Site Full Prescribing Information and Medication Guide COVID-19 and KESIMPTA For US Residents onl |
Keywords | N/A |
WebSite | kesimpta.com |
Host IP | 217.114.85.100 |
Location | Sweden |
Site | Rank |
US$148,150,316
Last updated: 2023-05-03 20:12:31
kesimpta.com has Semrush global rank of 71,443. kesimpta.com has an estimated worth of US$ 148,150,316, based on its estimated Ads revenue. kesimpta.com receives approximately 17,094,268 unique visitors each day. Its web server is located in Sweden, with IP address 217.114.85.100. According to SiteAdvisor, kesimpta.com is safe to visit. |
Purchase/Sale Value | US$148,150,316 |
Daily Ads Revenue | US$136,755 |
Monthly Ads Revenue | US$4,102,625 |
Yearly Ads Revenue | US$49,231,490 |
Daily Unique Visitors | 1,139,618 |
Note: All traffic and earnings values are estimates. |
Host | Type | TTL | Data |
kesimpta.com. | A | 86397 | IP: 217.114.85.100 |
kesimpta.com. | NS | 1800 | NS Record: a2-66.akam.net. |
kesimpta.com. | NS | 1800 | NS Record: a1-254.akam.net. |
kesimpta.com. | NS | 1800 | NS Record: a24-65.akam.net. |
kesimpta.com. | NS | 1800 | NS Record: a9-65.akam.net. |
kesimpta.com. | NS | 1800 | NS Record: a7-64.akam.net. |
kesimpta.com. | NS | 1800 | NS Record: a28-67.akam.net. |
kesimpta.com. | TXT | 86400 | TXT Record: facebook-domain-verification=5kwg95rl0wwubyqvklg17m39vv9c97 |
For US Residents only Visit US Health Care Professionals Site Full Prescribing Information and Medication Guide COVID-19 and KESIMPTA For US Residents only Home About KESIMPTA What is KESIMPTA? See the Results Understanding Safety Taking KESIMPTA KESIMPTA Stories Patient Support Personalized Support KESIMPTA Resources FAQs COVID-19 FAQs Enroll Now Visit US Health Care Professionals Site Full Prescribing Information and Medication Guide COVID-19 and KESIMPTA TAKE ON RMS CHALLENGES WITH DRAMATIC RESULTS. In 2 studies vs AUBAGIO ® (teriflunomide), KESIMPTA ® was proven superior at reducing the rate of relapses and active lesions, and slowing disability progression. See KESIMPTA Results Walt D. has taken KESIMPTA and has been compensated for his time. For adults only. Walt D. has taken KESIMPTA and has been compensated for his time. For adults only. WHAT PATIENTS ARE SAYING I’m a busy mom and student. I need a treatment that can reduce my relapses and delay my disability progression. – |
HTTP/1.0 301 Moved Permanently Location: https://www.kesimpta.com/ Server: BigIP Connection: Keep-Alive Content-Length: 0 HTTP/2 200 date: Tue, 26 Oct 2021 00:53:32 GMT content-type: text/html; charset=utf-8 cache-control: private vary: Accept-Encoding set-cookie: ASP.NET_SessionId=n1ef2gxemskcabvzt40grpiu; path=/; secure; HttpOnly; SameSite=Lax set-cookie: ASP.NET_SessionId=n1ef2gxemskcabvzt40grpiu; path=/; secure; HttpOnly; SameSite=Lax set-cookie: __RequestVerificationToken=WmKqKgOKMkq6Aggfds-ilO7mB30EHBXEgpVvIECoMgvNnUi-SeB9klGstT8WmXCN1yS8C2uhs6L-XuU-T8w5rHJfHW1m0Ulgt-XHpdODUXc1; path=/; secure; HttpOnly content-security-policy: default-src 'self' 'unsafe-inline' 'unsafe-eval' data: blob: fonts.googleapis.com fonts.gstatic.com www.googletagmanager.com www.google-analytics.com www.google.com sb.scorecardresearch.com b.scorecardresearch.com *.doubleclick.net *.kaltura.com novartispharma.hb.omtrdc.net novartispharma.sc.omtrdc.net dpm.demdex.net analytics.google.com api.fouanalytics.com *.vo.msecnd.net dc.services.visualstudio.com *.b2c.com di.rlcdn.com adservice.google.com *.episerver.net insight.adsrvr.org bat.bing.com servedby.flashtalking.com; request-context: appId=cid-v1:fbded6d8-2f5c-4cb0-adf7-2ae9d814644f access-control-expose-headers: Request-Context x-xss-protection: 1; mode=block x-content-type-options: nosniff strict-transport-security: max-age=31536000; includeSubDomains x-frame-options: SAMEORIGIN set-cookie: ARRAffinity=7b65e78aa202bf281b88a5638721aa4f837c46d0fd75afabdef0cb2870a44461;Path=/;HttpOnly;Secure;Domain=www.kesimpta.com set-cookie: ARRAffinitySameSite=7b65e78aa202bf281b88a5638721aa4f837c46d0fd75afabdef0cb2870a44461;Path=/;HttpOnly;SameSite=None;Secure;Domain=www.kesimpta.com cf-cache-status: DYNAMIC expect-ct: max-age=604800, report-uri="https://report-uri.cloudflare.com/cdn-cgi/beacon/expect-ct" server: cloudflare cf-ray: 6a3fb5492909c510-ORD |
Domain Name: KESIMPTA.COM Registry Domain ID: 2208127682_DOMAIN_COM-VRSN Registrar WHOIS Server: whois.markmonitor.com Registrar URL: http://www.markmonitor.com Updated Date: 2021-05-11T18:24:06Z Creation Date: 2018-01-03T09:14:05Z Registry Expiry Date: 2022-01-03T09:14:05Z Registrar: MarkMonitor Inc. Registrar IANA ID: 292 Registrar Abuse Contact Email: abusecomplaints@markmonitor.com Registrar Abuse Contact Phone: +1.2083895740 Domain Status: clientDeleteProhibited https://icann.org/epp#clientDeleteProhibited Domain Status: clientTransferProhibited https://icann.org/epp#clientTransferProhibited Domain Status: clientUpdateProhibited https://icann.org/epp#clientUpdateProhibited Name Server: A1-254.AKAM.NET Name Server: A2-66.AKAM.NET Name Server: A24-65.AKAM.NET Name Server: A28-67.AKAM.NET Name Server: A7-64.AKAM.NET Name Server: A9-65.AKAM.NET DNSSEC: unsigned >>> Last update of whois database: 2021-09-14T02:29:59Z <<< |